Skip to main content

Table 2 Accompanying diagnostic codes in incident pulmonary alveolar proteinosis cases after registration

From: Pulmonary alveolar proteinosis in Korea: analysis of prevalence and incidence via a nationwide population-based study

 

Total

Male

Female

Dyslipidaemia (E78)

54 (60.7)

38 (66.7)

16 (50.0)

Diabetes mellitus (E10–14)

36 (40.5)

26 (45.6)

10 (31.3)

Hypertension (I10–15)

36 (40.5)

24 (42.1)

12 (37.5)

Chronic obstructive pulmonary disease (J44)

21 (23.6)

17 (29.8)

4 (12.5)

Ischaemic heart disease (I20–25)

11 (12.4)

9 (15.8)

2 (6.3)

Malignancy (C00–97)

9 (10.1)

4 (7.0)

5 (15.6)

Tuberculosis (A15–19)

5 (5.6)

4 (7.0)

1 (3.1)

Non-tuberculous mycobacteria (A31.9)

1 (1.1)

1 (1.8)

0 (0.0)

Arrhythmia (I47–49)

4 (4.5)

3 (5.3)

1 (3.1)

Renal failure (N17–19)

3 (3.4)

2 (3.5)

1 (3.1)

Asbestosis (J61)

1 (1.1)

1 (1.8)

0 (0.0)

  1. Data are presented as number (%)